Chapter-28 Gliptins are Better than SGLT-2 Inhibitors for the Management of Diabetes Mellitus
BOOK TITLE: RSSDI Diabetes Update 2016
Author
1. Mittal Vinod
ISBN
9789386261144
DOI
10.5005/jp/books/13026_29
Edition
1/e
Publishing Year
2017
Pages
6
Author Affiliations
1.
Delhi Heart and Lung Institute, New Delhi, India,
Centre for Diabetes and Metabolic Diseases, Delhi Heart and Lung Institute, New Delhi, India,
Delhi Heart and Lung Institute; Delhi Diabetes Care Center, New Delhi, India,
Delhi Heart & Lung Institute; Sir Ganga Ram Hospital; Delhi Diabetes Care Centre, New Delhi, India,
Delhi Heart and Lung Institute, New Delhi; Delhi Diabetes Care Centre, New Delhi, India; RSSDI Delhi Chapter,
Centre for Diabetes and Metabolic, Diseases - Delhi Heart and Lung Institute; Sir Ganga Ram Hospital; Delhi Diabetes Care Centre,
New Delhi, India,
Delhi Heart and Lung Institute; Delhi Diabetes Care Centre, New Delhi, India,
Delhi Heart and Lung Institute, New Delhi; Delhi Diabetes Care Center, New Delhi, India
Chapter keywords
Gliptin,
diabetes mellitus,
hyperglucagonemia,
insulin resistance,
neurotransmitter dysregulation,
dipeptidyl peptidase-4,
DPP-4,
incretin
